Barclays Maintains an 'Overweight' on Celgene (CELG) Heading Into EU Decision; Shares Could Jump to Mid-$70s

Go back to Barclays Maintains an 'Overweight' on Celgene (CELG) Heading Into EU Decision; Shares Could Jump to Mid-$70s
Celgene Corp. (NASDAQ: CELG) Delayed: 108.24 --0 (-0%)
Previous Close $108.24    52 Week High $127.00 
Open $7.85    52 Week Low $93.05 
Day High $108.24    P/E 32.12 
Day Low $108.24    EPS $3.37 
Volume